Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAYER HLTHCARE

  • FDA Approval
  • June 21, 2023, 04:28 UTC
  • 31
  • 0 comments

FDA approve IOPROMIDE

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • June 21, 2023, 04:21 UTC
  • 30
  • 0 comments

FDA approve IOPROMIDE

Comment Full text

GENENTECH INC

  • FDA Approval
  • June 20, 2023, 17:53 UTC
  • 34
  • 0 comments

FDA approve ENTRECTINIB

Comment Full text

ASTRAZENECA UK LTD

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 29
  • 0 comments

FDA approve DURVALUMAB

Comment Full text

SPECTRUM PHARMS

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 28
  • 0 comments

FDA approve EFLAPEGRASTIM-XNST

Comment Full text

ABBVIE

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 27
  • 0 comments

FDA approve NEBIVOLOL HYDROCHLORIDE; VALSARTAN

Comment Full text

ALLERGAN

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 29
  • 0 comments

FDA approve NEBIVOLOL HYDROCHLORIDE

Comment Full text

OMNIVIUM PHARMS

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 27
  • 0 comments

FDA approve SODIUM BICARBONATE

Comment Full text

ALEMBIC

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 30
  • 0 comments

FDA approve CARBOPROST TROMETHAMINE

Comment Full text

MEITHEAL

  • FDA Approval
  • June 19, 2023, 12:48 UTC
  • 33
  • 0 comments

FDA approve CYTARABINE

Comment Full text
  • Previous
  • 776
  • 777
  • 778
  • 779
  • 780
  • Next

Search

News categories

  • Technical Exchange News(12076)
  • Event(5381)
  • SEC News(252102)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150532)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin